Loading…

Associations between vaginal bacteria and levels of vaginal defensins in pregnant women

Objective We evaluated vaginal defensin concentrations and levels of bacterial vaginosis–associated bacterial species in pregnant women. Study Design Self-collected vaginal swabs from 2 visits during pregnancy were tested with quantitative polymerase chain reaction for 9 bacterial species. Beta defe...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2013-02, Vol.208 (2), p.132.e1-132.e7
Main Authors: Mitchell, Caroline, MD, MPH, Gottsch, Michelle L., PhD, Liu, Congzhou, BS, Fredricks, David N., MD, Nelson, Deborah B., PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective We evaluated vaginal defensin concentrations and levels of bacterial vaginosis–associated bacterial species in pregnant women. Study Design Self-collected vaginal swabs from 2 visits during pregnancy were tested with quantitative polymerase chain reaction for 9 bacterial species. Beta defensins 2-3 and alpha defensins 1-3 were measured by enzyme-linked immunosorbent assay. Results Our 126 participants were primarily African American (60%), had a mean gestational age at enrollment of 10 ± 3 weeks and at follow-up visit of 25 ± 6 weeks. At enrollment, the prevalence of bacterial vaginosis was 74% (94/126 women), which decreased to 60% (75/126 specimens) at follow-up visit. At enrollment, beta defensin 3 concentrations were significantly lower in women with bacterial vaginosis (2.64 ± 0.91 vs 3.25 ± 0.99 log10 pg/mL; P = .003). Higher concentrations of Atopobium vaginae , bacterial vaginosis–associated bacteria1 and 2 were associated with significantly lower concentrations of beta defensin 3 ( P < .01). Conclusion Bacterial vaginosis was associated with lower vaginal concentrations of beta defensin 3, but not beta defensin 2 or alpha defensins 1-3, in pregnant women.
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2012.11.019